Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?

AbbVie Inc. (NYSE:ABBV) is one of the debt free halal stocks to buy. On March 3, at the TD Cowen 46th Annual Health Care Conference, AbbVie Inc. (NYSE:ABBV) affirmed its robust research and development pipeline, commercial strategies, and future growth plans.

Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy?

RAJ CREATIONZS / shutterstock.com

The company reiterated that it is on course to achieve a high single-digit compound annual growth rate through 2029. The growth will be driven by a diversified pipeline as the company increasingly focuses on bolstering its immunology, oncology, and neuroscience, with promising assets like SKYRIZI and RINVOQ.

AbbVie is also exploring B-cell-depleting strategies and mRNA-based CAR-T therapies for rheumatologic diseases. It’s also leveraging its expertise in immunology and CNS to develop an obesity drug. Even as it continues developing its pipeline, it is launching tavapadone to target a $5 billion market opportunity in Parkinson’s disease.

The pipeline development and launch of new drugs come on the heels of AbbVie increasing its research and development expenditure, with over $8 billion already spent on business development over the past two years.

AbbVie Inc. (NYSE:ABBV) is a global research-driven biopharmaceutical company focused on discovering, developing, and commercializing advanced therapies for complex, serious diseases. Key areas include immunology, oncology, neuroscience, eye care, and aesthetic medicine (via Allergan).

While we acknowledge the risk and potential of ABBV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ABBV and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.